Research Options: Select below IPO Calendar	Week of Expected Pricing Withdrawn Company Name Adnexus therapeutics, Inc. Proposed Ticker ADNX CUSIP N/A Business Description To build a leading biotechnology business that discovers, develops and commercializes our novel, proprietary drug class that we call Adnectins. Lead Underwriter Lehman Brothers, UBS Investment Bank Co-Managers Cowen and Company, Lazard Capital Markets Initial Shares N/A Revised Initial Shares N/A Initial Price N/A Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.